The Cow's Milk-related Symptom Score (CoMiSS (TM)) was developed as a clinical tool aimed at increasing the awareness of health care professionals for the presence and intensity of clinical manifestations possibly related to cow's milk (CM) intake. This review summarizes current evidence on CoMiSS. We found twenty-five original studies, one pooled analysis of three studies, and two reviews on CoMiSS. Infants exhibiting symptoms possibly related to CM, present with a higher median CoMiSS (6 to 13; 16 studies) than apparently healthy infants (median from 3 to 4; and mean 3.6-4.7; 5 studies). In children with cow's milk allergy (CMA), 11 studies found that a CoMiSS of >= 12 predicted a favorable response to a CM-free diet; however, sensitivity...
BACKGROUND: Cow's milk protein allergy (CMPA) is an immune-mediated allergic response to proteins in...
Importance Sales of specialized formula for managing cow’s milk allergy (CMA) have increased, trigg...
BACKGROUND: Non-IgE-mediated Cow's Milk Allergy (CMA) has a prevalence of less than 1% in children. ...
The Cow’s Milk-related Symptom Score (CoMiSS™) was developed as a clinical tool aimed at increasing ...
CoMiSS((R)) was developed 7 years ago to increase the awareness of health care professionals towards...
Clinicians with expertise in managing children with gastrointestinal problems and/or atopic diseases...
: CoMiSS® was developed 7 years ago to increase the awareness of health care professionals towards t...
Objective The Cow’s Milk-related Symptom Score (CoMiSSTM) was developed as an awareness tool to reco...
The Cow’s Milk-related Symptom Score (CoMiSS™) was developed as a clinical tool aimed at...
The symptoms of cow's milk protein allergy (CMPA) in infancy can be non-specific which may delay a c...
<div><p>Objective</p><p>The Cow’s Milk-related Symptom Score (CoMiSS<sup>TM</sup>) was developed as ...
The diagnosis of cow’s milk allergy (CMA) is particularly challenging in infants, especially with no...
Objectives The MOSAIC study aimed to evaluate if the Cow's Milk-related Symptom Score (CoMiSS) can b...
CoMiSS® was developed 7 years ago to increase the awareness of health care professionals towards...
The purpose of this study was to evaluate the diagnosis and management of infants presenting with sy...
BACKGROUND: Cow's milk protein allergy (CMPA) is an immune-mediated allergic response to proteins in...
Importance Sales of specialized formula for managing cow’s milk allergy (CMA) have increased, trigg...
BACKGROUND: Non-IgE-mediated Cow's Milk Allergy (CMA) has a prevalence of less than 1% in children. ...
The Cow’s Milk-related Symptom Score (CoMiSS™) was developed as a clinical tool aimed at increasing ...
CoMiSS((R)) was developed 7 years ago to increase the awareness of health care professionals towards...
Clinicians with expertise in managing children with gastrointestinal problems and/or atopic diseases...
: CoMiSS® was developed 7 years ago to increase the awareness of health care professionals towards t...
Objective The Cow’s Milk-related Symptom Score (CoMiSSTM) was developed as an awareness tool to reco...
The Cow’s Milk-related Symptom Score (CoMiSS™) was developed as a clinical tool aimed at...
The symptoms of cow's milk protein allergy (CMPA) in infancy can be non-specific which may delay a c...
<div><p>Objective</p><p>The Cow’s Milk-related Symptom Score (CoMiSS<sup>TM</sup>) was developed as ...
The diagnosis of cow’s milk allergy (CMA) is particularly challenging in infants, especially with no...
Objectives The MOSAIC study aimed to evaluate if the Cow's Milk-related Symptom Score (CoMiSS) can b...
CoMiSS® was developed 7 years ago to increase the awareness of health care professionals towards...
The purpose of this study was to evaluate the diagnosis and management of infants presenting with sy...
BACKGROUND: Cow's milk protein allergy (CMPA) is an immune-mediated allergic response to proteins in...
Importance Sales of specialized formula for managing cow’s milk allergy (CMA) have increased, trigg...
BACKGROUND: Non-IgE-mediated Cow's Milk Allergy (CMA) has a prevalence of less than 1% in children. ...